PAVmed Inc buy Zacks Research
Start price
11.10.25
/
50%
€0.20
Target price
11.10.26
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 11.10.26. The prediction end date can be changed by Zacks_Research at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PAVmed Inc | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Zacks_Research for this prediction
In the thread PAVmed Inc diskutieren
PAVmed (NASDAQ:PAVM) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PAVM provided by MarketBeat